unknown
Stage
1
Investors
About
Corion Biotech develops innovative therapeutic solutions for women's health by using placental-derived mesenchymal stromal cells to create cell-free therapies targeting conditions such as preeclampsia and epithelial cancers.
Explore Corion Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.